精神分裂症中的否认与接受应对方式及药物依从性
Denial and acceptance coping styles and medication adherence in schizophrenia.
作者信息
Aldebot Stephanie, de Mamani Amy G Weisman
机构信息
Department of Psychology, University of Miami, Coral Gables, FL 33124, USA.
出版信息
J Nerv Ment Dis. 2009 Aug;197(8):580-4. doi: 10.1097/NMD.0b013e3181b05fbe.
Abstract
Antipsychotics are often the first line of treatment for individuals with schizophrenia (). One challenge to effective treatment is lack of adherence to prescribed medication. Lower rates of adherence are associated with considerably higher rates of relapse and poorer course of illness. Therefore studying the characteristics that may be related to medication adherence is important. Coping styles may be one such factor. Individuals use a variety of coping mechanisms to manage and navigate difficult life events, including mental illness (). In the present study, 40 individuals with schizophrenia were assessed regarding their coping styles and medication adherence practices. As hypothesized, it was found that denial coping was inversely related to medication adherence. However, contrary to expectations, acceptance coping was not related to medication adherence. These findings suggest that targeting denial coping strategies in treatment may help foster more optimal strategies for managing schizophrenia.
摘要
抗精神病药物通常是精神分裂症患者的一线治疗药物。有效治疗面临的一个挑战是患者对医嘱用药的依从性差。依从率较低与复发率显著升高及病情转归较差相关。因此，研究可能与药物依从性相关的特征很重要。应对方式可能是其中一个因素。个体运用多种应对机制来处理和应对困难的生活事件，包括精神疾病。在本研究中，对40名精神分裂症患者的应对方式和药物依从性做法进行了评估。正如所假设的，发现否认应对与药物依从性呈负相关。然而，与预期相反，接受应对与药物依从性无关。这些发现表明，在治疗中针对否认应对策略可能有助于培养更优化的精神分裂症管理策略。
相似文献
1
Denial and acceptance coping styles and medication adherence in schizophrenia.精神分裂症中的否认与接受应对方式及药物依从性
J Nerv Ment Dis. 2009 Aug;197(8):580-4. doi: 10.1097/NMD.0b013e3181b05fbe.
2
Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication.我们是否在解决改善精神分裂症患者依从性的‘关键问题’？了解自知力和对药物治疗的态度的作用。
Schizophr Res. 2011 Oct;132(1):42-9. doi: 10.1016/j.schres.2011.07.019. Epub 2011 Aug 5.
3
Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia.症状严重程度和对药物的态度：对精神分裂症门诊患者依从性的影响。
Schizophr Res. 2012 Feb;134(2-3):226-31. doi: 10.1016/j.schres.2011.11.008. Epub 2011 Nov 30.
4
Early perception of medication benefit predicts subsequent antipsychotic response in schizophrenia: "the consumer has a point" revisited.早期对药物疗效的感知可预测精神分裂症患者后续的抗精神病药物反应：重温“患者有其道理”
Clin Schizophr Relat Psychoses. 2014 Jul;8(2):84-90, 90A. doi: 10.3371/CSRP.ASWE.022213.
5
Insight and medication adherence in schizophrenia: An analysis of the CATIE trial.精神分裂症患者的洞察力与药物依从性：对CATIE试验的分析
Neuropharmacology. 2020 May 15;168:107634. doi: 10.1016/j.neuropharm.2019.05.011. Epub 2019 May 9.
6
Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.抗精神病药物依从性评估中患者与临床医生观点的比较。
Psychopathology. 2009;42(5):311-7. doi: 10.1159/000232973. Epub 2009 Aug 11.
7
Measuring adherence to medication in schizophrenia: the relationship between attitudes toward drug therapy and plasma levels of new-generation antipsychotics.测量精神分裂症患者的药物依从性：对药物治疗的态度与新一代抗精神病药物血浆水平之间的关系。
Int J Neuropsychopharmacol. 2014 Dec 7;18(5):pyu091. doi: 10.1093/ijnp/pyu091.
8
Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS(®)) in the Swedish COAST-study.精神分裂症患者的药物态度和其他药物依从性预测因素：瑞典 COAST 研究中 12 个月的电子监测（MEMS(®)）。
Eur Neuropsychopharmacol. 2013 Dec;23(12):1754-62. doi: 10.1016/j.euroneuro.2013.09.001. Epub 2013 Sep 19.
9
Treatment adherence and insight in schizophrenia.精神分裂症的治疗依从性与自知力
Psychiatr Hung. 2015;30(1):18-26.
10
Negative impact of self-stigmatization on attitude toward medication adherence in patients with psychosis.自我污名化对精神病患者药物依从性态度的负面影响。
J Psychiatr Pract. 2014 Sep;20(5):405-10. doi: 10.1097/01.pra.0000454787.75106.ae.
引用本文的文献
1
The Relationship Between Level of Education, Cognitive Function and Medication Adherence in Patients with Schizophrenia.精神分裂症患者的教育水平、认知功能与药物依从性之间的关系
Neuropsychiatr Dis Treat. 2023 Nov 15;19:2439-2450. doi: 10.2147/NDT.S424694. eCollection 2023.
2
Association of Coping Strategies and Medication Adherence: A Systematic Review.应对策略与药物依从性的关联：一项系统综述。
Innov Pharm. 2022 Dec 12;13(3). doi: 10.24926/iip.v13i3.4991. eCollection 2022.
3
Stress Impact of COVID-19 Sports Restrictions on Disabled Athletes.新冠疫情对残疾人运动员体育赛事限制造成的压力影响。
Int J Environ Res Public Health. 2021 Nov 16;18(22):12040. doi: 10.3390/ijerph182212040.
4
Factors associated with dropout at 2 years post-initiation of treatment in the first episode of schizophrenia.首发精神分裂症治疗开始后2年脱落相关因素。
S Afr J Psychiatr. 2021 Mar 9;27:1657. doi: 10.4102/sajpsychiatry.v27i0.1657. eCollection 2021.
5
Antipsychotic Treatment Failure: A Systematic Review on Risk Factors and Interventions for Treatment Adherence in Psychosis.抗精神病药物治疗失败：关于精神病治疗依从性的危险因素和干预措施的系统评价
Front Neurosci. 2020 Oct 9;14:531763. doi: 10.3389/fnins.2020.531763. eCollection 2020.
6
The SPUR Model: A Framework for Considering Patient Behavior.SPUR模型：一种考量患者行为的框架。
Patient Prefer Adherence. 2020 Jan 16;14:97-105. doi: 10.2147/PPA.S237778. eCollection 2020.
7
Medication Adherence and Coping Strategies in Patients with Rheumatoid Arthritis: A Cross-Sectional Study.类风湿关节炎患者的药物依从性及应对策略：一项横断面研究
Int J Rheumatol. 2019 Mar 4;2019:4709645. doi: 10.1155/2019/4709645. eCollection 2019.
8
Influence of an inconsistent appearance of antipsychotics on drug adherence in patients with schizophrenia.抗精神病药物外观不一致对精神分裂症患者药物依从性的影响。
Medicine (Baltimore). 2018 Nov;97(44):e12990. doi: 10.1097/MD.0000000000012990.
9
Self-Efficacy and Adherence Behaviors in Rheumatoid Arthritis Patients.类风湿关节炎患者的自我效能和依从性行为。
Prev Chronic Dis. 2018 Oct 18;15:E127. doi: 10.5888/pcd15.180218.
10
Coping strategies and quality of life in schizophrenia: cross-sectional study.精神分裂症的应对策略与生活质量：横断面研究
Neuropsychiatr Dis Treat. 2015 Dec 10;11:3041-8. doi: 10.2147/NDT.S96559. eCollection 2015.
本文引用的文献
1
Responsiveness to Threat and Incentive in Bipolar Disorder: Relations of the BIS/BAS Scales With Symptoms.双相情感障碍中对威胁和激励的反应性：BIS/BAS量表与症状的关系
J Psychopathol Behav Assess. 2001 Sep 1;23(3):133-143. doi: 10.1023/A:1010929402770.
2
A preliminary trial of adherence-coping-education (ACE) therapy for early psychosis.早期精神病性障碍的依从性应对教育（ACE）疗法初步试验。
J Nerv Ment Dis. 2008 Jul;196(7):572-5. doi: 10.1097/NMD.0b013e31817d01a5.
3
Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia.首发精神分裂症患者抗精神病药物治疗的依从性、复发及再次住院情况
BMC Psychiatry. 2008 Apr 30;8:32. doi: 10.1186/1471-244X-8-32.
4
Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.快感缺失和社会适应能力可预测双相诊断精神分裂症患者的物质滥用演变情况。
Am J Drug Alcohol Abuse. 2008;34(1):75-82. doi: 10.1080/00952990701764631.
5
A large-scale validation study of the Medication Adherence Rating Scale (MARS).药物依从性评定量表（MARS）的大规模验证研究。
Schizophr Res. 2008 Mar;100(1-3):53-9. doi: 10.1016/j.schres.2007.10.029. Epub 2007 Dec 20.
6
Insight in schizophrenia: a review of etiological models and supporting research.精神分裂症的见解：病因模型及相关研究综述
Compr Psychiatry. 2008 Jan-Feb;49(1):70-7. doi: 10.1016/j.comppsych.2007.08.001. Epub 2007 Oct 23.
7
Relationships between insight and psychosocial adjustment in patients with bipolar I disorder.双相I型障碍患者领悟力与心理社会适应之间的关系。
Bipolar Disord. 2007 Nov;9(7):737-42. doi: 10.1111/j.1399-5618.2007.00406.x.
8
The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia.使用个性化定制的环境支持措施来提高精神分裂症患者的药物依从性及治疗效果。
Schizophr Bull. 2008 May;34(3):483-93. doi: 10.1093/schbul/sbm111. Epub 2007 Oct 10.
9
Relationships among subjective and objective measures of adherence to oral antipsychotic medications.口服抗精神病药物依从性的主观与客观测量指标之间的关系。
Psychiatr Serv. 2007 Sep;58(9):1187-92. doi: 10.1176/ps.2007.58.9.1187.
10
Insight, distress and coping styles in schizophrenia.精神分裂症中的洞察力、痛苦与应对方式
Schizophr Res. 2007 Aug;94(1-3):12-22. doi: 10.1016/j.schres.2007.04.030. Epub 2007 Jun 11.
Zotero 插件